| Variable | Patients with T2D and no previous evidence of CKD stages G3–5 (n = 32 276) |
|---|---|
| Median age, years (IQR) | 60 (50–70) |
| Sex, n (%) | |
| Female | 13 865 (43.0) |
| Male | 18 411 (57.0) |
| Median duration of follow-up, years (IQR) | 5.01 (2.31–6.00) |
| Median duration of diabetes, years (IQR) | 1.8 (0.0–7.0) |
| CKD diagnosis code, n (%) | 1463 (4.5) |
| Median time to diagnosis code, years (IQR) | 3.10 (1.49–5.41) |
| eGFR-based CKD, n (%) | 2667 (8.3) |
| Median time to lab-based CKD, years (IQR) | 2.66 (1.26–4.41) |
| Lab-based or coded CKD, n (%) | 3102 (9.6) |
| Median time to lab-based or coded CKD, years (IQR) | 2.52 (1.12–4.36) |
| Deprivation decile, n (%) | |
| 1–2 (highly deprived) | 13 945 (43.2) |
| 3–4 | 6070 (18.8) |
| 5–6 | 3309 (10.3) |
| 7–10 (least deprived) | 8952 (27.7) |
| General practices, n | 60 |
| Median number of patients per practice (IQR) | 472 (277–603) |
CKD = chronic kidney disease. eGFR = estimated glomerular filtration rate. IQR = interquartile range. T2D = type 2 diabetes.